OP0284 Muc5b Promoter Variant Rs35705950 Is a Risk Factor for Rheumatoid Arthritis – Interstitial Lung Disease

doi 10.1136/annrheumdis-2018-eular.4727
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians

Journal of Clinical Medicine
2019English

Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

Clinical and Developmental Immunology
2013English

The Lung in Rheumatoid Arthritis - Focus on Interstitial Lung Disease

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Interstitial Lung Disease of the UIP Variant as the Only Presenting Symptom of Rheumatoid Arthritis

Case Reports in Pulmonology
2015English

Is Air Pollution a Risk Factor for Rheumatoid Arthritis?

Journal of Inflammation
Clinical BiochemistryCell Biology
2015English

Current Perspectives on Emerging Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease

Open Access Rheumatology: Research and Reviews
Rheumatology
2019English

Adalimumab-Induced Acute Interstitial Lung Disease in a Patient With Rheumatoid Arthritis

Jornal Brasileiro de Pneumologia
PulmonaryRespiratory Medicine
2014English

Interstitial Lung Disease as an Extra-Articular Manifestation of Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2013English

Impact of Radiological Honeycombing in Rheumatoid Arthritis-Associated Interstitial Lung Disease

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy